Definition
Denial rate is the share of claims denied on initial adjudication: denied claims ÷ claims adjudicated, by count or by dollars (track both — a low count rate can hide high-dollar concentration). Distinguish denials (adjudicated refusals) from rejections (pre-adjudication bounces); mixing them muddles both metrics.
Benchmarks and the Trend Behind Them
Industry surveys in recent years consistently put average initial denial rates around 10–12% and rising — payer automation has made denying cheap. Well-run practices hold initial rates in the mid single digits. But the headline number is the least useful part of denial analytics; the mix is where the action is.
The Category Analysis That Matters
Classify every denial by root cause:
- Eligibility/registration — coverage and data failures (front-desk workflow)
- Authorization — missing or mismatched approvals (scheduling workflow)
- Coding — bundling, modifiers, documentation mismatches (coding review)
- Medical necessity — policy criteria disputes (documentation and appeals)
- Timely filing — deadline losses (pure process failure)
- Duplicate/technical — submission mechanics
Each category has an owner and a fix. A 9% rate dominated by preventable categories is a process indictment; a 6% rate concentrated in contested medical-necessity fights may reflect appropriate aggression against payer policies. The mix tells you which story you are in.
The Companion Metrics
- Denial overturn rate: appealed denials decided your way — published analyses repeatedly show large shares of appealed denials succeed, while most denials are never appealed at all
- Denial write-off rate: denied dollars ultimately lost — the number denial management exists to shrink
- Denials by payer: one plan’s edits often drive a disproportionate share; the data supports both targeted workflow and contracting conversations
How to Reduce It
Prevention by category: verification cadence for eligibility, scheduling gates for authorization, edit screening and documentation feedback for coding, submission discipline for timely filing. Meanwhile work the inventory: triage by deadline and value, appeal the winnable with evidence, write off true losses fast with documented reasons.
Common Errors
- Counting rejections as denials (or vice versa), corrupting both trends
- Tracking the rate without the category mix, guaranteeing untargeted effort
- Ignoring dollar-weighted analysis while high-value denials hide in a low count rate
- Treating a stable rate as fine while the same preventable categories recur monthly
Practical Checklist
- Denials and rejections measured separately
- Category classification on every denial
- Count and dollar rates both tracked, by payer
- Monthly prevention review converting categories into fixes
- Overturn and write-off rates reported beside the denial rate
Frequently Asked Questions
Is a rising denial rate always our fault? No — payer-side tightening is real and industry-wide. But the response is the same either way: category analytics to separate what prevention can fix from what appeals must fight, and payer-level data to support escalation where a plan’s behavior is the outlier.
What share of denials should we appeal? The winnable share — determined by triage, not by a quota. Appeal where evidence is strong and value justifies effort; correct-and-resubmit the fixable; close true losses quickly. Blanket appealing wastes capacity exactly where it is scarcest.